From the Centers for Disease Control and Prevention. Cardiac valvulopathy associated with exposure to fenfluramine or dexfenfluramine: US Department of Health and Human Services interim public health recommendations, November 1997.
D016907:Adverse Drug Reaction Reporting Systems; D001067:Appetite Depressants / Q000009:adverse effects*; D004452:Echocardiography; D005277:Fenfluramine / Q000009:adverse effects*; D006349:Heart Valve Diseases / Q000139:chemically induced* / Q000453:epidemiology; D006350:Heart Valve Prosthesis; D006801:Humans; D010645:Phentermine / Q000009:adverse effects; D014481:United States / Q000453:epidemiology; D014486:United States Food and Drug Administration
D001067:Appetite Depressants; D005277:Fenfluramine; D010645:Phentermine